J.Jpn. Surg. Soc.. 93(9): 1153-1155, 1992
Report on the annual meeting
CLINICAL EVALUATION OF ENDOSCOPIC INJECTION SCLEROTHERAPY AND ESOPHAGEAL TRANSECTION
|
The First Department of Surgery, School of Medicine, St. Marianna University, Kawasaki, Japan Masaru Hagiwara, Masahiro Sakai, Siro Nagaoka, Suehiro Nakano, Toru Okano, Takahiro Okada, Kenji Katayama |
One hundred and forty-seven patients underwent esophageal transection and 244 patients injection sclerotherapy in our institute.
1. The 5-year cumulative survival rate in patients with EIS was 58%, while 62% in those with transection.
2. Judging from the findings of varices after treatment which showed the negative redcolor sign, or changes from F2 or F3 to F1, the effect of two methods were 72% in operation group and 73% in EIS group, respectively.
3. There was no significant difference in the rates of rebleeding between EIS (7.8%) and operation (10.2%) groups.
4. Prognosis of esophageal varices treated with EIS or operation was considered to depend on the Child's classificantion.
We conclude that endoscopic sclerotherapy should be considered to be the first choice of treatment for esophageal varices.
To read the PDF file you will need Adobe Reader installed on your computer.